Rxcurve
HCPCS J2151 · per 250 MG

Inj, mannitol, 250 mg

Products billed under this code include Mannitol.

Payment limit per 250 MG, by effective quarter, 4Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J2151

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Mannitol Henry Schein Inc. 00404-9905-50 50 $5.60
Mannitol Pfizer Inc 00409-4031-01 1250 $140.00
Mannitol ICu Medical Inc. 00990-7715-02 4800 $537.60
Mannitol ICu Medical Inc. 00990-7715-03 4800 $537.60
Mannitol HF Acquisition Co. LLC, DBA HealthFirst 51662-1468-01 50 $5.60
Mannitol HF Acquisition Co. LLC, DBA HealthFirst 51662-1468-03 1250 $140.00
Mannitol FreseniUS Kabi USA, LLC 63323-0024-25 50 $5.60

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $0.112 +$0.041 250 MG Inj, mannitol, 250 mg v1, posted September 17, 2026
3Q26 $0.071 +$0.018 250 MG Inj, mannitol, 250 mg v1, posted September 15, 2026
2Q26 $0.053 −$0.007 250 MG Inj, mannitol, 250 mg v1, posted September 15, 2026
1Q26 $0.06 −$0.001 250 MG Inj, mannitol, 250 mg v1, posted September 15, 2026
4Q25 $0.061 – 250 MG Inj, mannitol, 250 mg v1, posted September 8, 2026

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files